Biotech-Hanse is a non-for profit organization, situated in Stockholm, Sweden. It is run by volunteers and the positions held are elected by its members.
All of the members have a media presence on LinkedIn and we welcome anyone interested to connect with us individually!
The members and their current positions are (list not yet fully complete):
All of the members have a media presence on LinkedIn and we welcome anyone interested to connect with us individually!
The members and their current positions are (list not yet fully complete):
Dr. Dirk Weigelt, Chairman. After Dirk's education in Germany, his career spans over 14 years at the department for Medicinal Chemistry at AstraZeneca R&D Södertälje where he worked in several local and global roles. After co-founding and leading KeytoLead AB for 2 years, he headed the Special Laboratory Unit at the department for Clinical Pathology, Karolinska University Hospital Huddinge, and subsequently Unilab's Clinical Chemistry Volume Lab. At present, he is director for Analysis at RISE - Research Institutes of Sweden. Dirk is a co-founder of Biotech Hanse. He served as treasurer from the start and was elected chairman in June of 2017. Find me on LinkedIn here!
Dr. Andreas Nolting, Treasurer. Andreas has more than 15 years’ experience in biomedical research from working appointments in the pharmaceutical industry and academia. With a background in Molecular Biology he has worked at AstraZeneca in Södertälje Sweden for nealry 6 years and is currently employed as scientist in the Division of Neurobiology at Linköping University. In 2015 he earned a master in “Innovation Management” from the Royal Institute of Technology, Stockholm. Andreas has become a member of Biotech-Hanse in 2015 and was appointed Treasurer since June 2017. Find me on LinkedIn here!
Judith Kairies, member, has a master of science in Bio-entrepreneurship and is currently working at PlantVision as consultant within regulatory affairs and quality with focus on medical devices and in vitro diagnostics.
Learn more on LinkedIn!
Learn more on LinkedIn!
Dr. Marijke Sachweh, project leader. Marijke has over 10 years of experience in the life science sector. She performed cancer research as a PhD student and postdoc at the Karolinska Institute followed by positions up to senior level at the CMO Cobra Biologics and the medtech companies ImmunoIVD and Cepheid. Currently, she works with drug documentation (CMC) as QA Officer at Fresenius Kabi. Marijke became a member of the Biotech Hanse in 2017 and was appointed project leader in 2018.
Connect on LinkedIn!
Connect on LinkedIn!
Dr. Johan Schultz, member. Following academic positions in Germany (FMP, Berlin and EMBL, Heidelberg), he has worked >20 years with drug discovery project management in both big Pharma (Pharmacia Corporation) and biotechs (Biovitrum, iNovacia and Kancera). He is currently Project Director at Kancera AB.
Found out more on LinkedIn!
Found out more on LinkedIn!
Dr. Suzanna Queckbörner, secretary, recently defended her PhD on cell therapy and immune-mediated diseases at Karolinska Institute. Currently Suzanna is conducting post-doctoral research in health economics on cell and gene therapy pricing and reimbursement associated to the Riken Centre for Biosystems Dynamics in Kobe, Japan. She is also a founding member of Stockholm Consulting Circle, a pro-bono strategic consultancy for life science tech-transfer. Find me on LinkedIn here!
Dr. Marc Willuhn, board member. After a PhD in organic chemistry at the Max Planck Institute for Coal Research and a postdoc at the Faculte de Pharmacie in Paris, he developed API syntheses at Schering AG in Germany and Sigma Aldrich in the UK. At Baxter Healthcare, based in Belgium, Marc was responsible for the global process development team for sterile injectables, before moving to Sweden to lead the pharmaceutical development of parenteral nutrition products for Fresenius Kabi. He is now an independent CMC consultant.
Contact me on LinkedIn!
Contact me on LinkedIn!